Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Coluzzi F, Ruggeri M. Clinical and economic evaluation of tapentadol ER and oxycodone/naloxone ER in comparison with CR oxycodone in musculoskeletal pain. Current Medical Research and Opinion 2014; 30(6): 1139-1151 Indexing Status Subject indexing assigned by NLM MeSH Chronic Pain /drug therapy; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Italy; Musculoskeletal Pain /drug therapy; Naloxone /administration & Oxycodone /administration & Phenols /administration & Treatment Outcome; dosage /adverse effects /economics; dosage /adverse effects /economics; dosage /adverse effects /economics AccessionNumber 22014010399 Date bibliographic record published 06/06/2014 |